×

Amicus jumps 28 percent after FDA speeds approval process for drug

11:44 AM ET Tue, 11 July 2017

CNBC's Meg Tirrell reports on the Food and Drug Administration's reversal on a ruling to run an additional late clinical stage study for a rare disease drug.